Oncolytics Biotech Inc
TSX:ONC
Oncolytics Biotech Inc
Cash from Investing Activities
Oncolytics Biotech Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Oncolytics Biotech Inc
TSX:ONC
|
Cash from Investing Activities
CA$20.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Cash from Investing Activities
-$207.3m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Investing Activities
$78m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Investing Activities
-$42.8m
|
CAGR 3-Years
41%
|
CAGR 5-Years
-107%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Investing Activities
$17.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Investing Activities
-CA$185k
|
CAGR 3-Years
15%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is Oncolytics Biotech Inc's Cash from Investing Activities?
Cash from Investing Activities
20.2m
CAD
Based on the financial report for Dec 31, 2023, Oncolytics Biotech Inc's Cash from Investing Activities amounts to 20.2m CAD.